LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 4 Mar 2025
Medicines recall

Pemetrexed SUN 10 mg/ml solution for infusion (Infusion bag)

Issued on 4 Mar 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Affected batches: HAF1473A (31/05/2026), HAF0544A (28/02/2026)
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 2 recall · 2 products · DMRC-34805959 · PL 31750/0193 · licence holder: Sun Pharmaceutical Industries Europe B.V. · active ingredient: Pemetrexed disodium heptahydrate · licence PL 31750/0193

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 2 recall · DMRC-34805959

ProductLicenceActive ingredientGTIN
Pemetrexed SUN 10 mg/ml solution for infusion (Infusion bag)PL 31750/0193Pemetrexed disodium heptahydrate8719323332256
Pemetrexed SUN 8 mg/ml solution for infusion (Infusion bag)PL 31750/0190Pemetrexed disodium heptahydrate8719323332195

Batches (expiry): HAF1473A (31/05/2026), HAF0544A (28/02/2026)

Background: Sun Pharmaceutical Industries Europe B.V. is recalling those product batches listed in this notification as a precautionary measure due to out of specification results reported for the Particulate Matter Test (PMT) during stability testing. Advice for Healthcare Professionals: Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process. This medicine is being recalled as a precautionary measure and should present no direct harm to patients who have already received these batches.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.